Please assess the completion status of the following clinical trial:

Trial Title: Thalidomide Low Threshold in Epilepsy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Refractory Epilepsy, males~Exclusion Criteria:~* Females, peripheric neuropathy

- Gender: MALE
- Minimum Age: 17 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Thalidomide (Type: EXPERIMENTAL): Open-labeled preliminary trial

Based on this trial design, predict the completion outcome and termination type (if applicable).